BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36568641)

  • 21. Retracted: The Effect of miR-138 on the Function of Follicular Helper T Cells and the Differentiation of B Cells in Osteosarcoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9802328. PubMed ID: 37946954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retracted: Interfering with pak4 Protein Expression Affects Osteosarcoma Cell Proliferation and Migration.
    International BR
    Biomed Res Int; 2024; 2024():9849782. PubMed ID: 38549986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retracted] MicroRNA‑93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells.
    He Y; Yu B
    Exp Ther Med; 2024 Mar; 27(3):101. PubMed ID: 38356669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retracted: Strontium/Chitosan/Hydroxyapatite/Norcantharidin Composite That Inhibits Osteosarcoma and Promotes Osteogenesis In Vitro.
    International BR
    Biomed Res Int; 2024; 2024():9893086. PubMed ID: 38550145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retracted: Effect of Paclitaxel Combined with Doxorubicin Hydrochloride Liposome Injection in the Treatment of Osteosarcoma and MRI Changes before and after Treatment.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9816837. PubMed ID: 37501833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retracted: A Cohort Study to Evaluate the Efficacy and Value of CT Perfusion Imaging in Patients with Metastatic Osteosarcoma after Chemotherapy.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9805234. PubMed ID: 37503439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retracted: Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment.
    International BR
    Biomed Res Int; 2024; 2024():9786305. PubMed ID: 38550142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retracted: Efficacy of Neoadjuvant Chemotherapy plus Limb-Sparing Surgery for Osteosarcoma and Its Impact on Long-Term Quality of Life.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9850186. PubMed ID: 38093877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retracted: Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases.
    International BR
    Biomed Res Int; 2024; 2024():9834610. PubMed ID: 38550158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retracted: Increased EHHADH Expression Predicting Poor Survival of Osteosarcoma by Integrating Weighted Gene Coexpression Network Analysis and Experimental Validation.
    International BR
    Biomed Res Int; 2024; 2024():9782859. PubMed ID: 38550210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retracted: Effects of Treadmill Exercise on Mitochondrial DNA Damage and Cardiomyocyte Telomerase Activity in Aging Model Rats Based on Classical Apoptosis Signaling Pathway.
    International BR
    Biomed Res Int; 2023; 2023():9764925. PubMed ID: 37388373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retracted: Candidate Genes of Allergic Dermatitis Are Associated with Immune Response.
    Engineering JOH
    J Healthc Eng; 2023; 2023():9826180. PubMed ID: 36636668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retracted: Value Analysis of Using Urinary Microalbumin in Artificial Intelligence Medical Institutions to Detect Early Renal Damage in Diabetes.
    Engineering JOH
    J Healthc Eng; 2022; 2022():9871586. PubMed ID: 36437816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retracted: Proanthocyanidins Antagonize Arsenic-Induced Oxidative Damage and Promote Arsenic Methylation through Activation of the Nrf2 Signaling Pathway.
    Oxidative Medicine and Cellular Longevity
    Oxid Med Cell Longev; 2021; 2021():3547620. PubMed ID: 33552384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retracted: PKC
    Longevity OMAC
    Oxid Med Cell Longev; 2022; 2022():9826078. PubMed ID: 35251484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retracted: Comprehensive Medical Analysis of Clinical Diseases and Syndromes Based on Rheumatoid Factor Interfering Immune Blood Cell Damage.
    Engineering JOH
    J Healthc Eng; 2023; 2023():9754351. PubMed ID: 36721760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retracted: Prediction Effect of Amplitude-Integrated EEG on the Brain Damage and Long-Term Nervous System Development of Late Preterm Infants.
    Healthcare Engineering JO
    J Healthc Eng; 2022; 2022():9820596. PubMed ID: 36478788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retracted: Integrated Analysis of DNA Repair Genes Identifies SLC6A1 as a New Marker for the Clinical Outcome of Patients with Colorectal Cancer.
    Markers D
    Dis Markers; 2023; 2023():9874383. PubMed ID: 37538096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retracted: MKP-1 Overexpression Reduces Postischemic Myocardial Damage through Attenuation of ER Stress and Mitochondrial Damage.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9825789. PubMed ID: 37868732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retracted: The Method of Pose Judgment of Potential Motion Damage in 3D Image Analysis.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9878026. PubMed ID: 37476787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.